In a recent study published in the journal PLOS ONE, researchers conducted a systematic review and meta-analyzed data on the impact of coronavirus disease 2019 (COVID-19) on male reproductive hormones and semen variables to determine whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections had an adverse impact on male fertility.
Background
The etiological agent of the COVID-19 pandemic, SARS-CoV-2, is a β-coronavirus that infects human cells by binding to the angiotensin-converting enzyme-2 (ACE-2) receptor. The ACE-2 receptor is found in the lungs, kidneys, heart, and testes, making all these organs possible entry points for the virus.
The COVID-19 pandemic was responsible for over 700 million cases and more than 7 million deaths. However, although the virus is known to primarily infect the respiratory system, research indicates that it can also adversely impact other organ systems. Studies have also found that SARS-CoV-2 infections are more severe in males than in females. Furthermore, studies have found that many males who had been infected with the earlier SARS-CoV-1 had developed orchitis or inflammation of the testes.
However, the data on the impact of SARS-CoV-2 on male reproductive health has been limited. Although some studies have reported associations between COVID-19 and decreased testosterone levels and lower semen quality, some of the findings have been considered methodologically weak.
About the study
The present study aimed to comprehensively review recent studies examining the impact of COVID-19 on male fertility and conducted a meta-analysis by comparing semen quality variables and reproductive hormone levels between infected and uninfected men to understand the influence of SARS-CoV-2 on male fertility.
The researchers used the PECO, or Population, Exposure, Comparator, and Outcomes, model to select studies that examined male patients of reproductive age who had been exposed to SARS-CoV-2. The review included both prospective and retrospective studies as long as they included COVID-19-negative controls or contained pre- and post-COVID-19 pandemic health data for the same individual. Studies that were in vitro, focused on female patients, or lacking control groups were excluded.
For the studies included in the review, the outcomes consisted of measurements of conventional semen parameters such as sperm count, ejaculate volume, sperm concentration, morphology, motility, and viability of the sperm, as well as leukocyte levels in the seminal fluid. The outcomes also included the levels of the male reproductive hormones, including testosterone, estrogen, prolactin, luteinizing hormone (LH), and follicle-stimulating hormone (FSH). The Measurements also included ratios of testosterone to LH and FSH to LH.
For the meta-analysis, the data extracted from the studies consisted of sample sizes, country of study, study design, the methods used to diagnose COVID-19, and key outcomes. The researchers used this data to calculate standardized mean differences, with extensive sensitivity analyses to avoid bias and assess sources of diversity. The parameters were also compared for changes before and after treatment for COVID-19.
Results
The review identified 40 eligible studies published from 12 different countries between 2020 and 2023 that examined the impact of SARS-CoV-2 on male reproductive health. The key findings from the meta-analysis covered the impact of COVID-19 on several aspects of male reproductive health.
The study found that COVID-19 was significantly associated with decreased ejaculate volume, with sensitivity analyses confirming consistent reductions in ejaculate volume after SARS-CoV-2 infections. However, the sensitivity analyses showed that the difference in ejaculate volume before and after COVID-19 treatment was not statistically significant, indicating that the impact of treatment may be limited. The sperm counts also decreased after SARS-CoV-2 infections, although the sensitivity analyses indicated that these reductions were marginal.
Individuals infected with SARS-CoV-2 also showed significantly lower sperm concentrations, and no changes were seen in sperm concentrations after treatment for COVID-19. This finding remained consistent even after accounting for potential study biases and diversity, reinforcing the robustness of the result. COVID-19 was also found to lower sperm viability and motility, with the difference in sperm viability remaining consistent even after the sensitivity analysis.
Comparisons between infected and uninfected individuals revealed no significant differences in sperm morphology. However, comparisons of sperm morphology in the same individual before and after SARS-CoV-2 infections revealed lower levels of morphologically normal sperm. The analysis showed that while the overall morphology differences between infected and uninfected individuals were not significant, the within-individual changes suggest that SARS-CoV-2 may have a subtle but noteworthy effect on sperm morphology.
The reproductive hormone levels were also significantly altered in COVID-19 patients, with elevated prolactin and marginally higher estrogen levels in infected men. Interestingly, the study found substantial variability in testosterone levels before and after treatment, suggesting that COVID-19’s impact on this hormone may be more complex than initially understood. However, the leukocyte levels in the seminal fluid were similar between infected and uninfected men.
Conclusions
To summarize, the study reviewed and conducted a meta-analysis of studies examining the impact of COVID-19 on male reproductive health and found that SARS-CoV-2 had a significant negative impact on male fertility, particularly on parameters such as ejaculate volume, viability, and motility of the sperm, and sperm concentration and count. Although the treatment of COVID-19 partially alleviated some of the affected parameters, the findings suggest that these improvements may not be sufficient to restore pre-infection levels, particularly for parameters like sperm concentration and motility. The study also highlighted the need for further research to fully understand the long-term effects of COVID-19 on male fertility and to explore potential therapeutic interventions.
- V. J., Ashonibare, P. J., Ashonibare, T. M., Akhigbe, & E, A. R. (2024). SARS-CoV-2 impairs male fertility by targeting semen quality and testosterone level: A systematic review and meta-analysis. PLOS ONE, 19(9), e0307396-. DOI:10.1371/journal.pone.0307396, https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0307396
News
Does being infected or vaccinated first influence COVID-19 immunity?
A new study analyzing the immune response to COVID-19 in a Catalan cohort of health workers sheds light on an important question: does it matter whether a person was first infected or first vaccinated? [...]
We May Never Know if AI Is Conscious, Says Cambridge Philosopher
As claims about conscious AI grow louder, a Cambridge philosopher argues that we lack the evidence to know whether machines can truly be conscious, let alone morally significant. A philosopher at the University of [...]
AI Helped Scientists Stop a Virus With One Tiny Change
Using AI, researchers identified one tiny molecular interaction that viruses need to infect cells. Disrupting it stopped the virus before infection could begin. Washington State University scientists have uncovered a method to interfere with a key [...]
Deadly Hospital Fungus May Finally Have a Weakness
A deadly, drug-resistant hospital fungus may finally have a weakness—and scientists think they’ve found it. Researchers have identified a genetic process that could open the door to new treatments for a dangerous fungal infection [...]
Fever-Proof Bird Flu Variant Could Fuel the Next Pandemic
Bird flu viruses present a significant risk to humans because they can continue replicating at temperatures higher than a typical fever. Fever is one of the body’s main tools for slowing or stopping viral [...]
What could the future of nanoscience look like?
Society has a lot to thank for nanoscience. From improved health monitoring to reducing the size of electronics, scientists’ ability to delve deeper and better understand chemistry at the nanoscale has opened up numerous [...]
Scientists Melt Cancer’s Hidden “Power Hubs” and Stop Tumor Growth
Researchers discovered that in a rare kidney cancer, RNA builds droplet-like hubs that act as growth control centers inside tumor cells. By engineering a molecular switch to dissolve these hubs, they were able to halt cancer [...]
Platelet-inspired nanoparticles could improve treatment of inflammatory diseases
Scientists have developed platelet-inspired nanoparticles that deliver anti-inflammatory drugs directly to brain-computer interface implants, doubling their effectiveness. Scientists have found a way to improve the performance of brain-computer interface (BCI) electrodes by delivering anti-inflammatory drugs directly [...]
After 150 years, a new chapter in cancer therapy is finally beginning
For decades, researchers have been looking for ways to destroy cancer cells in a targeted manner without further weakening the body. But for many patients whose immune system is severely impaired by chemotherapy or radiation, [...]
Older chemical libraries show promise for fighting resistant strains of COVID-19 virus
SARS‑CoV‑2, the virus that causes COVID-19, continues to mutate, with some newer strains becoming less responsive to current antiviral treatments like Paxlovid. Now, University of California San Diego scientists and an international team of [...]
Lower doses of immunotherapy for skin cancer give better results, study suggests
According to a new study, lower doses of approved immunotherapy for malignant melanoma can give better results against tumors, while reducing side effects. This is reported by researchers at Karolinska Institutet in the Journal of the National [...]
Researchers highlight five pathways through which microplastics can harm the brain
Microplastics could be fueling neurodegenerative diseases like Alzheimer's and Parkinson's, with a new study highlighting five ways microplastics can trigger inflammation and damage in the brain. More than 57 million people live with dementia, [...]
Tiny Metal Nanodots Obliterate Cancer Cells While Largely Sparing Healthy Tissue
Scientists have developed tiny metal-oxide particles that push cancer cells past their stress limits while sparing healthy tissue. An international team led by RMIT University has developed tiny particles called nanodots, crafted from a metallic compound, [...]
Gold Nanoclusters Could Supercharge Quantum Computers
Researchers found that gold “super atoms” can behave like the atoms in top-tier quantum systems—only far easier to scale. These tiny clusters can be customized at the molecular level, offering a powerful, tunable foundation [...]
A single shot of HPV vaccine may be enough to fight cervical cancer, study finds
WASHINGTON -- A single HPV vaccination appears just as effective as two doses at preventing the viral infection that causes cervical cancer, researchers reported Wednesday. HPV, or human papillomavirus, is very common and spread [...]
New technique overcomes technological barrier in 3D brain imaging
Scientists at the Swiss Light Source SLS have succeeded in mapping a piece of brain tissue in 3D at unprecedented resolution using X-rays, non-destructively. The breakthrough overcomes a long-standing technological barrier that had limited [...]
